ImpediMed Limited ( ASX:IPD – Get Rating ) insider David Anderson purchased 920,000 shares of ImpediMed stock in a transaction on Tuesday, June 20th. The stock was bought at an average cost of A$0.16 ($0.10) per share, for a total transaction of A$144,440.00 ($96,293.33). ImpediMed Stock Performance The company has a debt-to-equity ratio of 3.26, a quick ratio of 6.23 and a current ratio of 5.47. ( Get Rating ) ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.
https://www.dailypolitical.com/2023/06/28/impedimed-limited-asxipd-insider-purchases-a144440-00-in-stock.html#dailypolitical